AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Annual Report Jul 22, 2014

4924_10-k_2014-07-22_c1237eef-cfce-46b9-9267-4245240e742f.html

Annual Report

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0363N

Assura Group Limited

22 July 2014

22 July 2014

For immediate release

Assura Group Limited

Annual Information Update

In accordance with Prospectus Rule 5.2, Assura Group Limited (the "Company") sets out below a summary of the information which has been published or made available to the public during the period 21 July 2013 to 20 July 2014.

This annual information update is required by and is being made pursuant to Article 10 of the Prospectus Directive (Prospective Rule 5.2) and not for any other purpose. Information is referred to in this update rather than included in full. The information referred to was up to date at the time it was published; however, some information may now be out of date.

1.         Regulatory Announcements

The following UK regulatory announcements have been issued through RNS, a Regulatory News Service. They can be viewed or downloaded from the London Stock Exchange website (www.londonstockexchange.com) in the Market News section, searching under the Company's code AGR.

Date Announcement
22 July 2013 Annual Report 2013
24 July 2013 Annual Information Update
12 August 2013 Interim Management Statement
16 August 2013 Appointment of Joint Corporate Broker
20 August 2013 Holding(s) in Company
11 September 2013 Acquisition of 32 medical centres for £62.5m
19 September 2013 Results of AGM
3 October 2013 Confirmation of Quarterly Interim Dividend
14 October 2013 Notifications of Major Interests in Shares
5 November 2013 Notification of Major Interest in Shares
5 November 2013 Director Declaration
25 November 2013 Sale of LIFT Investments
26 November 2013 Interim Results 2013
27 November 2013 Director/PDMR shareholding
27 November 2013 Director/PDMR shareholding
3 December 2013 Notification of Major Interest in Shares
3 December 2013 Director/PDMR shareholding
9 December 2013 Notification of Major Interest in Shares
9 December 2013 Notification of Major Interest in Shares
10 December 2013 Notification of Major Interest in Shares
11 December 2013 Notification of Major Interest in Shares
12 December 2013 Notification of Major Interest in Shares
20 December 2013 Confirmation of Quarterly Interim Dividend
2 January 2014 Director/PDMR shareholding
24 January 2014 Sale of LIFT Investments
24 January 2014 Director/PDMR shareholding
29 January 2014 Notification of Vesting of Share Award to PDMR
11 February 2014 Notification of Major Interest in Shares
13 February 2014 Notification of Major Interest in Shares
14 February 2014 Interim Management Statement
4 March 2014 Director/PDMR shareholding
2 April 2014 Confirmation of Quarterly Interim Dividend
23 May 2014 Preliminary results for the year ended 31 March 2014
10 June 2014 Confirmation of Quarterly Interim Dividend
13 June 2014 Acquisition of 28 medical centres for £107 million
20 June 2014 Annual Report & Notice of AGM
23 June 2014 Notification of Major Interest in Shares
1 July 2014 Notification of Major Interest in Shares
1 July 2014 Total Voting Rights and Issued Share Capital

2.         Documents filed at Companies House                                                                     

Date Announcement
16 August 2013 Group of Companies Accounts made up to 31/03/13
24 December 2013 BR010010 Business Change 09/12/13 Managing of Operations of the Group's Property, Pharmacy & Medical Business
24 December 2013 Change in objects 09/12/13 Healthcare Services

3.         Annual and interim reports

The Company's annual report for the year ended 31 March 2013, interim report for the six months to 30 September 2013 and annual report for the year ending 31 March 2014 can be downloaded from the Company's website at http://www.assuragroup.co.uk/investor-relations/reports-presentations/2014.aspx.

A copy of this annual information update and all documents referred to in it can be obtained from the Company's branch address:

Assura Group Limited

The Brew House

Greenalls Avenue

Warrington

Cheshire

WA4 6HL

For further information, please contact:

Jonathan Murphy

Company Secretary

Assura Group Limited

Tel: 01925 420660

Notes to Editors

Assura Group is a long-term investor in and developer of primary care property.  The company, headquartered in Warrington and listed on the London Stock Exchange, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community.  At 31 March 2014, Assura Group's property portfolio was valued at £668m.

Further information is available at www.assuragroup.co.uk 

This information is provided by RNS

The company news service from the London Stock Exchange

END

AIUUUUNRSBABUAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.